Michael Ladomery

Prof. Michael Ladomery

University of the West of England, Bristol, UK
orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 August 2023 in Oncogene
Verified
Journal Article
Open access
PDF file
GIUSEPPINA PISIGNANOGIUSEPPINA PISIGNANO
GIUSEPPINA PISIGNANO
DMDavid C. Michael
David C. Michael
TVTanvi H. Visal
Tanvi H. Visal
Radu PirlogRadu Pirlog
Radu Pirlog
Michael LadomeryMichael Ladomery
Michael Ladomery
George CalinGeorge Calin
George Calin
To date, thousands of highly abundant and conserved single-stranded RNA molecules shaped into ring structures (circRNAs) have been identified. CircRNAs are multifunctional molecules that have been shown to regulate gene expression transcriptionally and post-transcriptionally and exhibit distinct tissue- and development-specific expression patterns associated with a variety of normal and disease conditions, including cancer pathogenesis. Over the past years, due to their intrinsic stability and resistance to ribonucleases, particular attention has been drawn to their use as reliable diagnostic and prognostic biomarkers in cancer diagnosis, treatment, and prevention. However, there are some critical caveats to their utility in the clinic. Their circular shape limits their annotation and a complete functional elucidation is lacking. This makes their detection and biomedical application still challenging. Herein, we review the current knowledge of circRNA biogenesis and function, and of their involvement in tumorigenesis and potential utility in cancer-targeted therapy.

1 December 2011 in Cancer Cell
Verified
Journal Article
Closed access
EAElianna M. Amin
Elianna M. Amin
SOSebastian Oltean
Sebastian Oltean
JHJing Hua
Jing Hua
MGMelissa V.R. Gammons
Melissa V.R. Gammons
MHMaryam Hamdollah-Zadeh
Maryam Hamdollah-Zadeh
Michael LadomeryMichael Ladomery
Michael Ladomery

1 February 2010 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
DNDawid G. Nowak
Dawid G. Nowak
EAElianna Mohamed Amin
Elianna Mohamed Amin
EREmma S. Rennel
Emma S. Rennel
CHCoralie Hoareau-Aveilla
Coralie Hoareau-Aveilla
MGMelissa Gammons
Melissa Gammons
DBDave Bates
Dave Bates
Vascular endothelial growth factor (VEGF) is produced either as a pro-angiogenic or anti-angiogenic protein depending upon splice site choice in the terminal, eighth exon. Proximal splice site selection (PSS) in exon 8 generates pro-angiogenic isoforms such as VEGF165, and distal splice site selection (DSS) results in anti-angiogenic isoforms such as VEGF165b. Cellular decisions on splice site selection depend upon the activity of RNA-binding splice factors, such as ASF/SF2, which have previously been shown to regulate VEGF splice site choice. To determine the mechanism by which the pro-angiogenic splice site choice is mediated, we investigated the effect of inhibition of ASF/SF2 phosphorylation by SR protein kinases (SRPK1/2) on splice site choice in epithelial cells and in in vivo angiogenesis models. Epithelial cells treated with insulin-like growth factor-1 (IGF-1) increased PSS and produced more VEGF165 and less VEGF165b. This down-regulation of DSS and increased PSS was blocked by protein kinase C inhibition and SRPK1/2 inhibition. IGF-1 treatment resulted in nuclear localization of ASF/SF2, which was blocked by SPRK1/2 inhibition. Pull-down assay and RNA immunoprecipitation using VEGF mRNA sequences identified an 11-nucleotide sequence required for ASF/SF2 binding. Injection of an SRPK1/2 inhibitor reduced angiogenesis in a mouse model of retinal neovascularization, suggesting that regulation of alternative splicing could be a potential therapeutic strategy in angiogenic pathologies.

11 September 2013 in International Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
Michael LadomeryMichael Ladomery
Michael Ladomery
The vast majority of human genes are alternatively spliced. Not surprisingly, aberrant alternative splicing is increasingly linked to cancer. Splice isoforms often encode proteins that have distinct and even antagonistic properties. The abnormal expression of splice factors and splice factor kinases in cancer changes the alternative splicing of critically important pre-mRNAs. Aberrant alternative splicing should be added to the growing list of cancer hallmarks.

17 June 2024 in British Journal of Biomedical Science
Verified
Journal Article
Open access
JDJohn A. Drozdz
John A. Drozdz
Michael LadomeryMichael Ladomery
Michael Ladomery
The peer review process is a fundamental aspect of modern scientific paper publishing, underpinning essential quality control. First conceptualised in the 1700s, it is an iterative process that aims to elevate scientific literature to the highest standards whilst preventing publication of scientifically unsound, potentially misleading, and even plagiarised information. It is widely accepted that the peer review of scientific papers is an irreplaceable and fundamental aspect of the research process. However, the rapid growth of research and technology has led to a huge increase in the number of publications. This has led to increased pressure on the peer review system. There are several established peer review methodologies, ranging from single and double blind to open and transparent review, but their implementation across journals and research fields varies greatly. Some journals are testing entirely novel approaches (such as collaborative reviews), whilst others are piloting changes to established methods. Given the unprecedented growth in publication numbers, and the ensuing burden on journals, editors, and reviewers, it is imperative to improve the quality and efficiency of the peer review process. Herein we evaluate the peer review process, from its historical origins to current practice and future directions.

1 May 2007 in Cancer Letters
Verified
Journal Article
Closed access
Michael LadomeryMichael Ladomery
Michael Ladomery
SHSteven J. Harper
Steven J. Harper
DBDave Bates
Dave Bates